Lee Ainslie's GMED Position Overview
Lee Ainslie (via Maverick Capital LTD) currently holds 15,660 shares of Globus Medical, Inc. (GMED) worth $1.35 M, representing 0.02% of the portfolio. First purchased in 2021-Q2, this short-term holding has been held for 5 quarters.
Based on 13F filings, Lee Ainslie has maintained this position in GMED for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2026, adding 15,660 shares. Largest reduction occurred in Q4 2021, reducing 9,226 shares.
Analysis based on 13F filings available since 2013 Q2
Lee Ainslie's Globus Medical (GMED) Holding Value Over Time
Track share changes against reported price movement
Quarterly Globus Medical (GMED) Trades by Lee Ainslie
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +15,660 | New Buy | 15,660 | $86.16 |
| Q1 2022 | -1,307 | Sold Out | 0 | $0.00 |
| Q4 2021 | -9,226 | Reduce 87.59% | 1,307 | $71.92 |
| Q3 2021 | -410 | Reduce 3.75% | 10,533 | $76.62 |
| Q2 2021 | +10,943 | New Buy | 10,943 | $77.49 |
Lee Ainslie's Globus Medical Investment FAQs
Lee Ainslie first purchased Globus Medical, Inc. (GMED) in Q2 2021, acquiring 10,943 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Lee Ainslie has held Globus Medical, Inc. (GMED) for 5 quarters since Q2 2021.
Lee Ainslie's largest addition to Globus Medical, Inc. (GMED) was in Q1 2026, adding 15,660 shares worth $1.35 M.
According to the latest 13F filing for Q1 2026, Lee Ainslie's firm, Maverick Capital LTD, owns 15,660 shares of Globus Medical, Inc. (GMED), valued at approximately $1.35 M.
As of the Q1 2026 filing, Globus Medical, Inc. (GMED) represents approximately 0.02% of Lee Ainslie's publicly disclosed stock portfolio, making it one of their key holdings.
Lee Ainslie's peak holding in Globus Medical, Inc. (GMED) was 15,660 shares, as reported at the end of Q1 2026.